New treatment perspectives in autism spectrum disorders

Frontiers in Pediatrics

Volumn 3, Issue , 2015, Pages

  Canitano, Roberto ^a   Bozzi, Yuri ^b,c  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b UNIVERSITY OF TRENTO   (Italy)

^c CNR   (Italy)

Author keywords

Autism; Autism spectrum disorders; Autism spectrum disorders and treatment; Diagnostic markers; Pharmacology

Indexed keywords

EID: 85013784673     PISSN: None     EISSN: 22962360     Source Type: Journal    
DOI: 10.3389/fped.2015.00022     Document Type: Editorial

References (17)

1. Ecker C, Spooren W, Murphy DG. Translational approaches to the biology of autism: false dawn or a new era? Mol Psychiatry (2013) 18(4):435–42. doi:10.1038/mp.2012.102
2. Amiet C, Couchon E, Carr K, Carayol J, Cohen D. Are there cultural differences in parental interest in early diagnosis and genetic risk assessment for autism spectrum disorder? Front Pediatr (2014) 2:32. doi:10.3389/fped.2014.00032
3. Rossignol DA, Frye RE. The use of medications approved for Alzheimer’s disease in autism spectrum disorder: a systematic review. Front Pediatr (2014) 2:87. doi:10.3389/fped.2014.00087
4. Frye RE, Rossignol DA. Treatments for biomedical abnormalities associated with autism spectrum disorder. Front Pediatr (2014) 2:66. doi:10.3389/fped. 2014.00066
5. Napoli E, Dueñas N, Giulivi C. Potential therapeutic use of the ketogenic diet in autism spectrum disorders. Front Pediatr (2014) 2:69. doi:10.3389/fped.2014. 00069
6. Pini G, Scusa MF, Benincasa A, Bottiglioni I, Congiu L, Vadhatpour C, et al. Repeated insulin-like growth factor 1 treatment in a patient with rett syndrome: a single case study. Front Pediatr (2014) 2:52. doi:10.3389/fped.2014.00052
7. Canitano R. New experimental treatments for core social domain in autism spectrum disorders. Front Pediatr (2014) 2:61. doi:10.3389/fped.2014.00061
8. Tordjman S, Davlantis K, Georgieff N, Speranza M, Xavier J, Botbol M, et al. Autism as a disorder of biological and behavioral rhythms: towards new therapeutic perspectives. Front Pediatr (2015) 3:1. doi:10.3389/fped.2015.00001
9. Fulton E, Eapen V, Crnčec R, Walter A, Rogers S. Reducing maladaptive behaviors in preschool aged children with autism spectrum disorder using the early start denver model. Front Pediatr (2014) 2:40. doi:10.3389/fped.2014. 00040
10. Vivanti G, Prior M, Williams K, Dissanayake C. Predictors of outcomes in autism early intervention: why don’t we know more? Front Pediatr (2014) 2:58. doi:10.3389/fped.2014.00058
11. Porges SW, Bazhenova OV, Bal E, Carlson N, Sorokin Y, Heilman KJ, et al. Reducing auditory hypersensitivities in autistic spectrum disorder: preliminary findings evaluating the listening project protocol. Front Pediatr (2014) 2:80. doi:10.3389/fped.2014.00080
12. Corbett BA, Qualls LR, Valencia B, Fecteau SM, Swain DM. Peer-mediated theatrical engagement for improving reciprocal social interaction in autism spectrum disorder. Front Pediatr (2014) 2:110. doi:10.3389/fped.2014.00110
13. Cellot G, Cherubini E. GABAergic signaling as therapeutic target for autism-spectrum disorders. Front Pediatr (2014) 2:70. doi:10.3389/fped.2014.00070
14. Giovedí S, Corradi A, Fassio A, Benfenati F. Involvement of synaptic genes in the pathogenesis of autism spectrum disorders: the case of synapsins. Front Pediatr (2014) 2:94. doi:10.3389/fped.2014.00094
15. Provenzano G, Clementi E, Genovesi S, Scali M, Tripathi PP, Sgadò P, et al. GH dysfunction in engrailed-2 knockout mice, a model for autism spectrum disorders. Front Pediatr (2014) 2:92. doi:10.3389/fped.2014.00092
16. Gigliucci V, Leonzino M, Busnelli M, Luchetti A, Palladino VS, D’Amato FR, et al. Region specific up-regulation of oxytocin receptors in the opioid oprm1 (-/-) mouse model of autism. Front Pediatr (2014) 2:91. doi:10.3389/fped.2014.00091
17. Michetti C, Romano E, Altabella L, Caruso A, Castelluccio P, Bedse G, et al. Mapping pathological phenotypes in reelinmutant mice. Front Pediatr (2014) 2:95. doi:10.3389/fped.2014.00095